1,114 results on '"Beglinger, C"'
Search Results
202. Exocrine pancreatic function in patients with tropical chronic pancreatitis (TCP)
203. Influence of orlistat on gastric emptying rates of fats and solids in healthy subjects
204. [13C]octanoic acid breath test for gastric emptying of solids: Meal-to-meal variability
205. Clinical trial of 5-aminosalicylic acid (5-ASA) in acute Shigella colitis
206. Appropriateness of upper gastrointestinal endoscopy: Randomized trial of algorithm-based versus free clinical decision
207. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus
208. Helicobacter pylori: Prevalence, Transmission, and Serum Pepsinogen II Concentrations in Children of a Poor Periurban Community in Bangladesh
209. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy
210. Comparison of the Effects of the M1-Receptor Antagonist Telenzepine and the CCK-Receptor Antagonist Loxiglumide on the Pancreatic Secretory Response to Intraduodenal Tryptophan in Dogs
211. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation
212. Are CCK-8 effects on food-intake mediated via direct access to the brain?
213. Comparison of the Effects of Two Cholecystokinin-Receptor Antagonists, Loxiglumide and L-364,718, on the Pancreatic Secretory Response to Intraduodenal Tryptophan in Dogs
214. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations
215. Double-blind comparison of three different amoxicillin (AMO) plus omeprazole (OME) regimens for eradication of Helicobacter pylori (HP) in patients with peptic ulcer
216. Blockade of GRP receptors potently inhibits gastric emptying and gallbladder contraction in man
217. Peptide YY inhibits low-dose but not high-dose CCK-stimulated pancreatic enzyme secretion in humans
218. BIM 4004-1 is a novel PYY analog selective for Y2 receptors
219. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade
220. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors
221. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells
222. Cholecystokinin is a physiological regulator of gastric acid secretion in man
223. Circulating somatostatin-28 is not a physiologic regulator of gastric acid production in man
224. Low-Dose Octreotide Treatment Is Not Effective in Patients with Advanced Pancreatic Cancer
225. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers.
226. Effect of a Liquid Diet With and Without Soluble Fiber Supplementation on Intestinal Transit and Cholecystokinin Release in Volunteers
227. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man
228. Reply
229. Non-invasive assessment of gastrointestinal motility disorders in diabetic patients with and without cardiovascular signs of autonomic neuropathy.
230. Peptide YY (PYY) inhibits endogenously stimulated pancreatic enzyme secretion in man
231. Effects of a CCK-A receptor antagonist on gastric acid secretion in man
232. Intestinal phase of superior mesenteric artery blood flow in man.
233. Enteral absorption of octreotide
234. Diagnosis of Bacterial Overgrowth after Culturing Proximal Small-Bowel Aspirate Obtained during Routine Upper Gastrointestinal Endoscopy
235. The absorption site of cyclosporin in the human gastrointestinal tract.
236. Nonanesthesiologist-administered propofol sedation:from the exception to standard practice. Sedation and monitoring trends over 20 years.
237. Topische Therapie bei Colitis ulcerosa.
238. Reply
239. Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex.
240. Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects.
241. Duodenal phytohaemagglutinin (red kidney bean lectin) stimulates gallbladder contraction in humans.
242. Effects of budesonide on P-glycoprotein expression in intestinal cell lines.
243. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.
244. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis.
245. Calcitonin gene-related peptide (CGRP) causes redistribution of blood flow in humans
246. Cholecystokinin is a regulator of intestinal phase-stimulated PP release
247. Effect of tegaserod on gut transit in male and female subjects.
248. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
249. Tegaserod is safe, well tolerated and effective in the treatment of patients with non-diarrhoea irritable bowel syndrome.
250. Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.